![]() |
|
|
4 INRA, UR 909 Nutrition et Régulation Lipidique des Fonctions Cérébrales, F-78352 Jouy-en-Josas, France; 5 INSERM, U513 Neurobiologie et Psychiatrie, Université P & M Curie, F-75252 Paris 3, France; and 6 Institut des Neurosciences Cellulaires et Intégratives, Département de Neurobiologie des Rythmes, UMR 7168/LC2 CNRS-Université L. Pasteur, F-67000 Strasbourg, France
* To whom correspondence should be addressed. E-mail: monique.lavialle{at}jouy.inra.fr.
| ABSTRACT |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
-linolenic acid [LnA, 18:3(n-3)], respectively. Membrane phospholipids in neural tissues are particularly rich in DHA (1,2). Dietary (n-3) PUFA supply has been demonstrated to determine membrane DHA levels (3,4) and modulate diverse physiological processes affecting neuronal function (5–7) and melatonin secretion. A reduction in sulfatoxymelatonin, a urinary melatonin metabolite (8), and melatonin release in cultured pineal glands (9) were observed in rats deficient in (n-3) PUFA. An increase in the daytime pineal melatonin level was also described (10). Because (n-3) PUFA modulate the pineal system, we investigated the putative role of PUFA in the regulation of the circadian clock. Indeed, melatonin, synthesized and released by the pineal gland, reinforces the circadian message delivered by the circadian clock and distributes photoperiodic information, supporting the synchronization of numerous physiological functions with appropriate environmental cues (11,12). We compared the locomotor activity and pineal melatonin rhythms of Syrian hamsters fed a diet deficient in (n-3) PUFA to that of control hamsters. To investigate whether the observed wheel-running hyperactivity was related to an alteration of striatal dopaminergic neurotransmission (13), we measured endogenous monoamine concentrations in the striatum, a key structure playing a critical role in the initiation of movement (14). The fatty acid composition of the 2 main phospholipid classes, phosphatidylcholine (PC) and phosphatidylethanolamine (PE), was analyzed in the pineal gland and striatum.
| Materials and Methods |
|---|
|
|
|---|
1200 mg LA and 200 mg LnA/100 g of diet. The LnA-deficient diet included peanut oil and contained
1200 mg LA/100 g of diet. At weaning, female pups were culled and killed. Only the litter that contained at least 4 male pups was kept. The male pups were fed the same diet as their mother until 3 mo, when they were used for biochemical and cellular analysis. All animal experiments were performed in accordance with the European Communities Council Directive of 24 November 1986 (86/609/EEC).
|
Tissue collection. At the end of their assigned survival time, 3-mo-old hamsters were decapitated, the skull was gently lifted, the pineal gland was isolated, and the brain was quickly removed. The striatum were dissected on ice. The left striatum was used for lipid analysis and the right one for monoamine analysis.
Fatty acid analysis. Four pooled pineal glands were necessary to harvest sufficient quantities of phospholipids and to quantify PUFA in each phospholipid class. Striatum and pineal glands were homogenized on ice with 0.5 or 1 mL NaCl solution (9 g/L) containing butylhydroxytoluene (0.02 g/L), and their total lipids were then extracted according to Folch et al. (15). Phospholipid classes (PC and PE) were separated from total lipids by solid-phase extraction on a 500-mg aminopropyl-bonded silica column (Bakerbond spe Amino) (16). After evaporation under nitrogen, PC and PE were transmethylated in methanol containing 100 g/L boron trifluoride (Fluka, Socolab) at 90°C for 20 min. FAME were analyzed by GLC (17). Fatty acid composition was expressed as the percentage of total fatty acid weight.
Measurement of endogenous monoamine concentrations. The striatum were weighed and homogenized in 500 µL perchloric acid (0.05 mol/L), octanesulfonic acid (0.6 g/L), heptanesulfonic acid (0.6 g/L), EDTA (0.04 g/L) to inhibit biochemical degradation, and Na2S2O5 (0.1 g/L). Homogenates were centrifuged at 30,000 x g for 20 min at 4°C. The supernatant was stored at –80°C until use. Dopamine (DA), homovanillic acid (HVA), and 3,4-dihydroxyphenylacetic acid (DOPAC) were separated on a reverse-phase analytical column (C18 monoamines HB 4 µm, 100 mm x 2 mm, Phymep) using a mobile phase consisting of 90% citrate-phosphate buffer (20 mmol/L citric acid, 10 mmol/L monobasic phosphate sodium, 0.1 mmol/L EDTA, 4.5 mmol/L octanesulfonic acid, 3 mmol/L heptanesulfonic acid, 6 mL/L o-phosphoric acid, and 2 mL/L diethylamine), 7% (v:v) acetonitrile, and 3% methanol (v:v) at pH 2.5, adjusted using diethylamine. Compounds were electrochemically detected by oxidation on a glassy carbon electrode at 800 mV relative to an Ag-AgCl reference electrode and using an amperometric detector (Model L-EC 2000). The flow rate was 0.6 mL/min and the injection volume was 50 µL. Chromatographic data were processed with the Chromosystem program (Thermoquest). Monoamines were identified by comparison of the retention times to those of known external standards and their concentration was calculated by comparing the peak areas with those of standards determined twice a day before and after the set of analysis. Results are expressed in nmol/g wet tissue.
Melatonin assay. The pineal glands were collected either 2 h before or 2, 6, and 8 h after the onset of light off, when pineal melatonin content peaks (18). When the hamsters were killed during the dark phase, the procedure was performed under a red light. Melatonin was measured in 100-µL aliquots of hamster pineal homogenates. Melatonin radioimmunoassay was performed using a rabbit antiserum (R19540, INRA, provided by Dr.Jean-Paul Ravault) at a final dilution of 1:200,000 and 2-[125 iodomelatonin]. The sensitivity limit of the assay was 10 pg/pineal gland. This assay was previously validated for the Syrian hamster (19). Results are expressed in pg/pineal gland.
Statistical analysis. For phospholipid PUFA composition, we evaluated the effect of brain region and diet on 3 fatty acids [AA, (n-6) docosapentaenoic acid (DPA) [22:5(n-6)], and DHA] in PC and PE using a 2-way ANOVA with diet as the between-group factor and brain region as the within-group factor. For the effects of time of killing and diet on melatonin content, data were analyzed by a 2-way ANOVA with the diet as between-factor and the time as within-factor. When significant effects (P < 0.05) were detected, the Tukey test was used for post hoc comparisons. For locomotor activity and monoamine contents, the differences between control and (n-3) fatty acid-deficient groups were determined by a Mann and Whitney nonparametric test.
| Results |
|---|
|
|
|---|
Only PUFA that exhibited major changes are shown [AA, DHA, and (n-6) DPA, an (n-6) PUFA that replaces DHA in (n-3) fatty acid-deficient hamsters] (Table 2). In both the control and (n-3) PUFA-deficient groups, we detected varied concentrations of AA and DHA in both phospholipid classes among the 2 brain regions (P < 0.001). Moreover, for the 2 regions, there was a significant effect of diet (P < 0.001) on the amount of AA, DPA, and DHA.
|
(n-3) PUFA-deficient group. In the 2 structures of the (n-3) PUFA-deficient hamsters, the level of DHA in both PE and PC was significantly lower than in controls, whereas DPA levels were significantly higher in (n-3) PUFA-deficient hamsters. A significant interaction between brain region and diet was found for AA (P < 0.001), DPA (P < 0.001), and DHA (P < 0.001), indicating that diet had varying effects among the 2 regions. For PC, DHA was reduced by 83% in the pineal gland and by 60% in the striatum; AA increased by 35% in the pineal gland and was unchanged in the striatum. For PE, DHA was reduced by 76% in the pineal gland and 56% in the striatum; AA was increased by 20% in the pineal gland and unchanged in the striatum. The (n-3) PUFA-deficient diet was associated with a doubling of the AA:DHA ratio in the striatum and an even greater increase in the pineal gland (8-fold of the control for PC and 5-fold for PE).
Locomotor activity
Locomotor activity of hamsters maintained under a 14:10 LD cycle was monitored for at least 2 wk before the experiments were initiated. The number of wheel revolutions, duration, and distribution of locomotor activity were assessed.
In both the control and (n-3) PUFA-deficient groups, wheel-running activity clearly entrained to the LD cycle, with a predominantly nocturnal pattern (Supplemental Fig. 1). The number of wheel revolutions was 85% higher during the light phase and 68% during the dark phase in the (n-3) PUFA-deficient hamsters than in controls. The time spent in the wheel was also augmented by 1 h during the night (Table 3). The (n-3) PUFA-deficient hamsters exhibited not only a prolonged activity but also a hyperlocomotion as measured by the number of revolutions/hour that reached 70% of the control during the light phase (P = 0.045) and 50% during the dark phase (P < 0.001).
|
Melatonin rhythm
Analysis of pineal melatonin concentrations revealed that dark-phase pineal melatonin content was drastically reduced in the (n-3) PUFA-deficient group compared with controls (Fig. 1). No group difference was observed during the light phase or at the beginning of the dark phase when the pineal melatonin content was low.
|
In the striatum, the diets affected DA and DA metabolite concentrations (Table 4). DA, DOPAC, and HVA were, respectively, 29, 79, and 89% higher in (n-3) PUFA-deficient hamsters than in controls. Frontal cortex monoamine concentrations did not differ between the groups (data not shown).
|
| Discussion |
|---|
|
|
|---|
|
The resulting nocturnal melatonin decrease weakened the endogenous rhythm of the circadian clock. Indeed, the hamsters deficient in (n-3) PUFA re-entrained to a 6-h-phase delay in the LD cycle more quickly than controls. Previous findings agree with the idea that resynchronization of locomotor activity following a phase shift in the LD cycle is modulated by the daily rhythm of melatonin release (21,22). These data suggest that alteration of the melatonin rhythm enhances circadian sensitivity to light synchronizer and reduces the resistance of the timing system to photoperiod variations (23). Because melatonin is a hormone of darkness and is concerned with the timing and magnitude of events associated with the dark phase that differ in diurnal and nocturnal species, a chronic deficiency of melatonin production could be associated with decreased sleep quality in humans (24). In addition, we cannot exclude a direct effect of (n-3) PUFA-deficient diet on the functioning of the circadian clock and the melatonin rhythm (Fig. 2), because we previously demonstrated a decline in energy metabolism (glucose utilization and oxidative phosphorylation) in the brain and notably in the circadian clock of (n-3) PUFA-deficient rats (25,17).
Chronic hyperlocomotion and striatal melatonin-DA interaction. Apart from a disturbance in melatonin rhythm, we also observed a chronic locomotor hyperactivity. Numerous studies have investigated the effect of a diet deficient in (n-3) PUFA on general motor activity (26). Several reports found no incidence, whereas others described an increased locomotion in (n-3) PUFA-deficient rodents; however, the time lapse of the observations ranged from a few minutes to several hours. In our study, we used voluntary wheel running in the home cage as a continuous measurement of the locomotor activity of Syrian hamsters over several weeks. We found that a diet deficient in (n-3) PUFA (increasing the AA:DHA ratio in membrane phospholipids) induced lasting hyperlocomotion. These alterations were independent of exploratory behavior and, thus, here we especially detected locomotor hyperactivity. Interestingly, maternal exposure to a high (n-6) fatty acid diet during pregnancy [i.e. increasing the (n-6):(n-3) ratio] augmented locomotor activity of mice (27). Increased locomotor activity has also been described in spontaneously hypertensive rats, who exhibited low DHA content in synaptosomes (28). Similar observations were reported for impulsive rats fed a normal diet with a low level of DHA in the brain (29).
The (n-3) PUFA-deficient diet-induced hyperactivity justified examination of the striatal DA level in these hamsters deficient in (n-3) fatty acids, as the striatum is involved in the regulation of voluntary movement. The hyperlocomotion of the (n-3) PUFA-deficient hamsters was accompanied by higher DA and DA metabolite concentrations, indicating activation of DA metabolism and increased DA utilization in the striatum (Table 4). Dysregulation of monoaminergic systems in the frontal cortex and nucleus accumbens of rats deficient in (n-3) PUFA was previously reported (30); however, no change in striatal monoamine content was detected.
Several lines of evidence implicate melatonin in the regulation of dopaminergic pathways (31). Melatonin MT1 receptors and DA D2 receptors are colocalized in the striatum (32). In vivo studies showed that daily melatonin administration inhibits DA release (33) or reduces dopaminergic activity (34–37) in various areas of the rodent brain. Iontophoretic treatment with melatonin attenuated neuronal firing in the rat striatum and this effect was reversed by treatment with a DA D2 receptor antagonist (38). In our study, the increase in DA and DA metabolites in the striatum could be explained in part by the reduction in melatonin level.
Another factor to consider in accounting for the disturbances induced by dietary (n-3) PUFA deficiency is the effect of DHA reduction on membrane structural properties, including its alteration of the activity of membrane-bound proteins, such as enzymes, receptors, and transporters (39,40). Inactivation of the DA transporter produces spontaneous hyperlocomotion by prolonging the presence of DA in the extracellular space (41). The nocturnal hyperlocomotion displayed by D3-mutant mice (42,43) is associated with a high basal level of extracellular DA (44). A functional impact of (n-3) fatty acid deficiency on these membrane-bound proteins is possible and remains to be studied.
In conclusion, when diet did not support adequate (n-3) PUFA accretion in the brain, hamsters exhibited hyperlocomotion associated with striatal hyperdopaminergia. Moreover, alteration in melatonin function weakened the circadian clock function and could play a role in nocturnal sleep disturbances as described in children with attention deficit/hyperactivity disorder (45). Finally, our results suggest that an (n-3) PUFA-adequate diet could serve to normalize physiological and behavioral processes. Clinical trials are necessary to establish the potential efficacy of (n-3) PUFA in disturbances linked to hyperactivity disorder.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 Author disclosures: M. Lavialle, G. Champeil-Potokar, J. M. Alessandri, L. Balasse, P. Guesnet, C. Papillon, P. Pévet, S. Vancassel, B. Vivien-Roels, and I. Denis, no conflicts of interest. ![]()
3 Supplemental Figure 1 is available with the online posting of this paper at jn.nutrition.org. ![]()
7 Abbreviations used: AA, arachidonic acid; DA, dopamine; DHA, docosahexaenoic acid; DOPAC, 3,4-dihydroxyphenylacetic acid; DPA, docosapentaenoic acid; 12-HETE, 12-hydroxyeicosatetraenoic acid; HVA, homovanillic acid; LA, linoleic acid; LD, light dark; LnA,
-linolenic acid; PC, phosphatidylcholine; PE, phosphatidylethanolamine. ![]()
Manuscript received 13 March 2008. Initial review completed 12 May 2008. Revision accepted 17 June 2008.
| LITERATURE CITED |
|---|
|
|
|---|
1. Sinclair AJ. Long-chain polyunsaturated fatty acids in the mammalian brain. Proc Nutr Soc. 1975;34:287–91.[Medline]
2. Lauritzen LHH, Jorgensen MH, Michaelsen KF. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res. 2001;40:1–94.[Medline]
3. Bourre J-M, Francois M, Youyou A, Dumont O, Piciotti M, Pascal G, Durand G. The effects of dietary {alpha}-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. J Nutr. 1989;119:1880–92.
4. Guesnet P, Alasnier C, Alessandri JM, Durand G. Modifying the n-3 fatty acid content of the maternal diet to determine the requirements of the fetal and suckling rat. Lipids. 1997;32:527–34.[Medline]
5. Fernstrom JD. Effects of dietary polyunsaturated fatty acids on neuronal function. Lipids. 1999;34:161–9.[Medline]
6. Bazan NG. Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor. J Lipid Res. 2003;44:2221–33.
7. Alessandri JM, Guesnet P, Vancassel S, Astorg P, Denis I, Langelier B, Aid S, Poumes-Ballihaut C, Champeil-Potokar G, et al. Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life. Reprod Nutr Dev. 2004;44:509–38.[Medline]
8. Zaouali-Ajina M, Gharib A, Durand G, Gazzah N, Claustrat B, Gharib C, Sarda N. Dietary docosahexaenoic acid-enriched phospholipids normalize urinary melatonin excretion in adult (n-3) polyunsaturated fatty acid-deficient rats. J Nutr. 1999;129:2074–80.
9. Gazzah N, Gahrib A, Moliere P, Durand G, Christon R, Lagarde M, Sarda N. Effect of n-3 fatty acdic-deficient diet on the adenosine-dependent melatonin in cultured rat pineal. J Neurochem. 1993;61:1057–63.[Medline]
10. Zhang H, Hamilton JH, Salem N Jr, Kim H-Y. N-3 fatty acid deficiency in the rat pineal gland: effects on phospholipid molecular species composition and endogenous levels of melatonin and lipoxygenase products. J Lipid Res. 1998;39:1397–403.
11. Pevet P, Bothorel B, Slotten H, Saboureau M. The chronobiotic properties of melatonin. Cell Tissue Res. 2002;309:183–91.[Medline]
12. von Gall C, Stehle J, Weaver D. Mammalian melatonin receptors: molecular biology and signal transduction. Cell Tissue Res. 2002;309:151–62.[Medline]
13. Delion S, Chalon S, Herault J, Guilloteau D, Besnard JC, Durand G. Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. J Nutr. 1994;124:2466–76.
14. Graybiel AM, Aosaki T, Flaherty AW, Kimura M. The basal ganglia and adaptive motor control. Science. 1994;265:1826–31.
15. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497–509.
16. Goustard-Langelier B, Alessandri JM, Raguenez G, Durand G, Courtois Y. Phospholipid incorporation and metabolic conversion of n-3 polyunsaturated fatty acids in the Y79 retinoblastoma cell line. J Neurosci Res. 2000;60:678–85.[Medline]
17. Ximenes da Silva A, Lavialle F, Gendrot G, Guesnet P, Alessandri JM, Lavialle M. Glucose transport and utilization are altered in the brain of rats deficient in n-3 polyunsaturated fatty acids. J Neurochem. 2002;81:1328–37.[Medline]
18. Pitrosky B, Kirsch R, Vivienroels B, Georgbentz I, Canguilhem B, Pevet P. The photoperiodic response in Syrian hamster depends upon a melatonin-driven circadian rhythm of sensitivity to melatonin. J Neuroendocrinol. 1995;7:889–95.[Medline]
19. Pitrosky B, Massonpevet M, Kirsch R, Vivienroels B, Canguilhem B, Pevet P. Effects of different doses and durations of melatonin infusions on plasma melatonin concentrations in pinealectomized syrian hamsters: consequences at the level of sexual activity. J Pineal Res. 1991;11:149–55.[Medline]
20. Sakai K, Fafeur V, Vulliez-le Normand B, Dray F. 12-Hydroperoxyeicosatetraenoic acid (12-HPETE) and 15-HPETE stimulate melatonin synthesis in rat pineals. Prostaglandins. 1988;35:969–76.[Medline]
21. Quay W. Precocious entrainment and associated characteristics of activity patterns following pinalectomy and reversal of photoperiod. Physiol Behav. 1970;5:1281–90.[Medline]
22. Marumoto N, Murakami N, Kuroda H, Murakami T. Melatonin accelerates reentrainment of circadian locomotor activity rhythms to new light-dark cycles in the rat. Jpn J Physiol. 1996;46:347–51.[Medline]
23. Arendt J, Skene DJ. Melatonin as a chronobiotic. Sleep Med Rev. 2005;9:25–39.[Medline]
24. Scheer FAJL, Czeisler CA. Melatonin, sleep, and circadian rhythms. Sleep Med Rev. 2005;9:5–9.[Medline]
25. Pifferi F, Roux F, Langelier B, Alessandri JM, Vancassel S, Jouin M, Lavialle M, Guesnet P. (n-3) Polyunsaturated fatty acid deficiency reduces the expression of both isoforms of the brain glucose transporter GLUT1 in rats. J Nutr. 2005;135:2241–6.
26. Fedorova I, Salem JN. Omega-3 fatty acids and rodent behavior. Prostaglandins Leukot Essent Fatty Acids. 2006;75:271–89.[Medline]
27. Raygada M, Cho E, Hilakivi-Clarke L. High maternal intake of polyunsaturated fatty acids during pregnancy in mice alters offsprings' aggressive behavior, immobility in the swim test, locomotor activity and brain protein kinase c activity. J Nutr. 1998;128:2505–11.
28. Wei J, Yang L, Sun S, Chiang C. Phospholipids and fatty acid profile of brain synaptosomal membrane from normotensive and hypertensive rats. Int J Biochem Cell Biol. 1987;19:1225–8.
29. Vancassel S, Blondeau C, Lallemand S, Cador M, Linard A, Lavialle M, Dellu-Hagedorn F. Hyperactivity in the rat is associated with spontaneous low level of n-3 polyunsaturated fatty acids in the frontal cortex. Behav Brain Res. 2007;180:119–26.[Medline]
30. Chalon S. Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids. 2006;75:259–69.[Medline]
31. Zisapel N. Melatonin-dopamine interactions: from basic neurochemistry to a clinical setting. Cell Mol Neurobiol. 2001;21:605–16.[Medline]
32. Uz T, Arslan AD, Kurtuncu M, Imbesi M, Akhisaroglu M, Dwivedi Y, Pandey GN, Manev H. The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic system. Brain Res Mol Brain Res. 2005;136:45–53.[Medline]
33. Exposito I, Mora F, Zisapel N, Oaknin S. The modulatory effect of melatonin on the dopamine-glutamate interaction in the anterior hypothalamus during ageing. Neuroreport. 1995;6:2399–403.[Medline]
34. Alexiuk NA, Vriend J. Effects of daily afternoon melatonin administration on monoamine accumulation in median eminence and striatum of ovariectomized hamsters receiving pargyline. Neuroendocrinology. 1991;54:55–61.[Medline]
35. Alexiuk NA, Vriend JP. Melatonin reduces dopamine content in the neurointermediate lobe of male Syrian hamsters. Brain Res Bull. 1993;32:433–6.[Medline]
36. Alexiuk NA, Uddin M, Vriend J. Melatonin increases the in situ activity of tyrosine hydroxylase in the mediobasal hypothalamus of male Syrian hamsters. Life Sci. 1996;59:687–94.[Medline]
37. Khaldy H, Leon J, Escames G, Bikjdaouene L, Garcia JJ, Acuna-Castroviejo D. Circadian rhythms of dopamine and dihydroxyphenyl acetic acid in the mouse striatum: effects of pinealectomy and of melatonin treatment. Neuroendocrinology. 2002;75:201–8.[Medline]
38. Escames G, Acuna Castroviejo D, Vives F. Melatonin-dopamine interaction in the striatal projection area of sensorimotor cortex in the rat. Neuroreport. 1996;7:597–600.[Medline]
39. Giorgione J, Epand RM, Buda C, Farkas T. Role of phospholipids containing docosahexaenoyl chains in modulating the activity of protein kinase C. Proc Natl Acad Sci USA. 1995;92:9767–70.
40. Niu S-L, Mitchell DC, Lim S-Y, Wen Z-M, Kim H-Y, Salem N Jr, Litman BJ, Reduced G. Protein-coupled signaling efficiency in retinal rod outer segments in response to n-3 fatty acid deficiency. J Biol Chem. 2004;279:31098–104.
41. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 1996;379:606–12.[Medline]
42. Accili D, Fishburn CS, Drago J, Steiner H, Lachowicz JE, Park B-H, Gauda EB, Lee EJ, Cool MH, et al. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci USA. 1996;93:1945–9.
43. Betancur C, Lepée-Lorgeoux I, Cazillis M, Accili D, Fuchs S, Rostène W. Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D(3) receptor deficient mice. Neuropsychopharmacology. 2001;24:170–82.[Medline]
44. Joseph JD, Wang YM, Miles PR, Budygin EA, Picetti R, Gainetdinov RR, Caron MG, Wightman RM. Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D3 receptors. Neuroscience. 2002;112:39–49.[Medline]
45. O'Brien LM, Ivanenko A, Crabtree VM, Holbrook CR, Bruner JL, Klaus CJ, Gozal D. Sleep disturbances in children with attention deficit hyperactivity disorder. Pediatr Res. 2003;54:237–43.[Medline]
This article has been cited by other articles:
![]() |
J. Mendoza, P. Pevet, and E. Challet High-fat feeding alters the clock synchronization to light J. Physiol., December 15, 2008; 586(24): 5901 - 5910. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||